Global Hormone Replacement Therapy Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast 2018 to 2029

“Global Hormone Replacement Therapy Market” is the title of an upcoming report offered by MarketResearch.Biz. The research process involved the study of various factors positively or negatively impacting the industry and market. Factors considered include government policies and mandates, the market environment, competitive landscapes, historical data, current and historical trends in the market, technological innovations, new solutions and modifications made to existing provisions, upcoming technologies and the technical progress of related industries. The research study involved the extensive usage of expert opinions, using both primary and secondary data sources and efforts. Also, market risks, opportunities, growth market barriers and challenges, and future scenarios have been covered in the report. The global hormone replacement therapy market has been segmented on the basis of product, route of administration, type of disease, as well as regions and countries.

Request Covid - 19 Impact

Overview:

Hormone replacement therapy, also known as menopausal hormone therapy (MHT) or hormone therapy (HT) is a form of therapy that is used to treat symptoms associated with menopause. Challenges faced as a result of hormonal imbalance may range from weight gain, muscle loss, fatigue, low libido, memory decline, etc. MHT is used to balance estrogen and progesterone in women.

Dynamics:

The increasing number of women reaching the state of menopause as a result of the widening menopausal window (40-55 years) is projected to further lead to revenue growth of the global hormone replacement therapy market.

A factor that may hinder the growth of the global hormone replacement therapy market is the increased risk of forming gall-bladder stones and undergoing cholecystectomy (the removal of the gall-bladder) as a result of this therapy.

The global hormone replacement therapy market was valued at US$ XXX in 2019 and is projected to register a CAGR of XX% by 2028.

Segmentation of the global hormone replacement therapy market is as follows:

In terms of product, the estrogen replacement therapy segment accounted for the majority revenue share. The human growth hormone therapy segment is expected to register the fastest rate of revenue growth over the next 10 years owing to the rising incidences of growth deficiencies, especially among infants.

With respect to the route of administration aspect of the market, the parenteral segment accounted for the majority of the revenue share although the oral route of administration is the most preferred option.

Concerning type of disease, menopause is projected to be the fastest growing segment with approximately 6,000 women reaching menopause on a daily basis in North America.

Regional Segmentation and Analysis:

The market in North America accounted for the majority revenue share of the global hormone replacement therapy market in 2019. This can be accredited to factors such as the development of new formulations, drug delivery system innovations, and increasing target market, etc. The market in the Asia Pacific region is expected to register the fastest rate of revenue growth due to increasing levels of awareness and a more focused approach by healthcare providers to eradicate hormonal deficiencies in this region.

Segmentation of Global Hormone Replacement Therapy Market:

Segmentation by Product:

• Estrogen Hormone Replacement Therapy
• Human Growth Hormone Replacement Therapy
• Thyroid Hormone Replacement Therapy
• Testosterone Hormone Replacement Therapy

Segmentation by Route of Administration:

• Oral
• Parenteral
• Transdermal
• Others

Segmentation by Type of Disease:

• Menopause
• Hypothyroidism
• Male Hypogonadism
• Growth Hormone Deficiency
• Others

Segmentation by Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Abbott Laboratories
• Novartis
• Pfizer Inc.
• Mylan Laboratories
• Merck and Co.
• Novo Nordisk
• Bayer Healthcare
• Eli Lilly
• Genentech